Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-12

Clinical Trial Update: HU007 Eye Drops in Patients With Dry Eye Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for HU007 eye drops in dry eye syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HU007 eye drops (HU007 eye drops)

Snippet

Sponsor: Huons Co., Ltd. | Conditions: Dry Eye Syndromes | Phase 3 | Status: COMPLETED